CGON
Price
$22.63
Change
+$0.58 (+2.63%)
Updated
Apr 2, 02:47 PM (EDT)
Capitalization
1.87B
36 days until earnings call
OLMA
Price
$3.32
Change
-$0.02 (-0.60%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
228.23M
41 days until earnings call
Ad is loading...

CGON vs OLMA

Header iconCGON vs OLMA Comparison
Open Charts CGON vs OLMABanner chart's image
CG Oncology
Price$22.63
Change+$0.58 (+2.63%)
Volume$900
Capitalization1.87B
Olema Pharmaceuticals
Price$3.32
Change-$0.02 (-0.60%)
Volume$87.69K
Capitalization228.23M
CGON vs OLMA Comparison Chart
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. OLMA commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a StrongBuy and OLMA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (CGON: $22.05 vs. OLMA: $3.34)
Brand notoriety: CGON and OLMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 200% vs. OLMA: 125%
Market capitalization -- CGON: $1.87B vs. OLMA: $228.23M
CGON [@Biotechnology] is valued at $1.87B. OLMA’s [@Biotechnology] market capitalization is $228.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileOLMA’s FA Score has 1 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • OLMA’s FA Score: 1 green, 4 red.
According to our system of comparison, OLMA is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 4 TA indicator(s) are bullish while OLMA’s TA Score has 4 bullish TA indicator(s).

  • CGON’s TA Score: 4 bullish, 5 bearish.
  • OLMA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, OLMA is a better buy in the short-term than CGON.

Price Growth

CGON (@Biotechnology) experienced а -22.71% price change this week, while OLMA (@Biotechnology) price change was -20.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.91%. For the same industry, the average monthly price growth was -7.11%, and the average quarterly price growth was -11.65%.

Reported Earning Dates

CGON is expected to report earnings on May 08, 2025.

OLMA is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-4.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($1.87B) has a higher market cap than OLMA($228M). CGON YTD gains are higher at: -23.117 vs. OLMA (-42.710). CGON has higher annual earnings (EBITDA): -95.94M vs. OLMA (-135.54M). CGON has more cash in the bank: 541M vs. OLMA (215M). CGON has less debt than OLMA: CGON (296K) vs OLMA (1.7M). CGON has higher revenues than OLMA: CGON (684K) vs OLMA (0).
CGONOLMACGON / OLMA
Capitalization1.87B228M819%
EBITDA-95.94M-135.54M71%
Gain YTD-23.117-42.71054%
P/E RatioN/AN/A-
Revenue684K0-
Total Cash541M215M252%
Total Debt296K1.7M17%
TECHNICAL ANALYSIS
Technical Analysis
CGONOLMA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 22 days ago
75%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSMRX14.60N/A
N/A
RBC SMID Cap Growth R6
MRJIX10.70N/A
N/A
Morgan Stanley Multi-Asset Real Return I
PRPPX13.53N/A
N/A
Principal International Equity R3
HAVLX21.47N/A
N/A
Harbor Large Cap Value Instl
BDAIX26.61N/A
N/A
Baron Durable Advantage Institutional

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with SYRE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-9.96%
SYRE - CGON
48%
Loosely correlated
-5.21%
KRYS - CGON
46%
Loosely correlated
-3.17%
IDYA - CGON
44%
Loosely correlated
-9.83%
OLMA - CGON
43%
Loosely correlated
-11.17%
ACLX - CGON
43%
Loosely correlated
-7.47%
More

OLMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, OLMA has been loosely correlated with RCKT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if OLMA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OLMA
1D Price
Change %
OLMA100%
-11.17%
RCKT - OLMA
46%
Loosely correlated
-12.89%
AGIO - OLMA
45%
Loosely correlated
-6.48%
DNLI - OLMA
44%
Loosely correlated
-9.60%
IDYA - OLMA
43%
Loosely correlated
-9.83%
ARWR - OLMA
43%
Loosely correlated
-4.20%
More